Sign in / Join Now
ETFs & Funds
Believe we'll see additional upward pressure across biotechs with combo of $
deal and short covering. Love to see shorts get squeezed!
Can we add audio?
Would be great!
Add a reply...
Latest StockTalks »
people get OMED breaking news and analysis by email alert.
Get email alerts on OMED »
OncoMed Pharmaceuticals, Inc
Get latest price
From other sites
OncoMed Presents Interim Phase 1b Data For Ipafricept And Vantictumab In Pancreatic Cancer At The ESMO 2016 Congress
at TheStreet (Oct 10, 2016)
Noteworthy Friday Option Activity: OMED, HLF, CIA
at TheStreet (Sep 30, 2016)
OncoMed To Present Clinical Data For Wnt Inhibitors At The ESMO 2016 Congress
at TheStreet (Sep 29, 2016)
HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target
at Benzinga (Sep 22, 2016)
OncoMed Pharmaceuticals Completes Enrollment Of Phase 2 YOSEMITE Clinical Trial Of Demcizumab In Pancreatic Cancer
at TheStreet (Sep 1, 2016)